萬馬科技(300698.SZ):總經理韋練辭職 張禾陽補缺
格隆匯6月11日丨萬馬科技(300698.SZ)宣佈,公司董事會近日收到總經理韋練的書面辭職報告,因個人原因,韋練申請辭去公司總經理和公司下屬控股子公司安華智能股份公司監事會主席職務,韋練的原定任期為2019年6月4日至2021年7月19日,辭職後,其不再擔任公司任何職務。
經公司董事會提名委員會審核,提名張禾陽為公司總經理候選人,公司於2020年6月11日召開第二屆董事會第十二次會議,審議通過了《關於公司總經理辭職及聘任公司總經理的議案》,同意聘任張禾陽為公司總經理,任期自此次董事會決議通過之日起至公司第二屆董事會任期屆滿時止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.